Targeting of NF‐κB/NLRP3 Axis in Gestational Diabetes Mellitus
American Journal of Reproductive Immunology · 2025
DOI: 10.1111/aji.70188 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Asmaa Morgan Farahat Khatap und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal-Newborn Health Nursing, College of Nursing in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia. Hauptthemen laut MEDLINE: Diabetes, Gestational, NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B. Die Arbeit nennt 110 Literaturangaben. Gefördert von: Prince Sattam bin Abdulaziz University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Gestational diabetes mellitus (GDM) is a pregnancy‐associated metabolic disorder characterized by transient hyperglycemia resulting from impaired insulin sensitivity and β‐cell dysfunction. Increasing evidence suggests that inflammatory pathways, particularly the NLRP3 inflammasome and nuclear factor kappa B (NF‐κB), play crucial roles in initiating and perpetuating insulin resistance and glucose intolerance during GDM.
Methods
This review comprehensively examines the current literature on the molecular mechanisms linking the NLRP3/NF‐κB signaling axis to the development of GDM. Relevant studies were identified through database searches focusing on inflammation‐mediated insulin resistance, cytokine regulation, and therapeutic interventions targeting these pathways.
Results
Findings indicate that activation of the NLRP3 inflammasome and NF‐κB pathway enhances the production of proinflammatory cytokines, such as IL‐1β and TNF‐α, which contribute to pancreatic β‐cell dysfunction and insulin resistance. Experimental models demonstrate that inhibition of these signaling cascades mitigates inflammation, improves insulin sensitivity, and normalizes glucose metabolism, suggesting their critical involvement in GDM pathogenesis.
Conclusion
The NLRP3/NF‐κB axis plays a pivotal role in mediating inflammation and insulin resistance in GDM. Targeting this pathway may offer a promising therapeutic strategy for preventing or managing GDM. However, further research is needed to fully elucidate its molecular interactions and validate potential pharmacological interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Maternal-Newborn Health Nursing, College of Nursing in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
- Lecturer of Maternity Obstetrics & Gynecological Nursing, Faculty of Nursing, Suez Canal University, Ismailia, Egypt.
- Department of Clinical Pharmacology and Medicine, College Of Medicine, Mustansiriyah University, Baghdad, Iraq.
- Department of Gynecology and Obstetrics, College of Medicine, Al-Mustansiriyah University, Baghdad, Iraq.
- Head of Jabir ibn Hayyan Medical University, Najaf, Iraq.
- Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
ORCID-Profile: Asmaa Morgan Farahat Khatap, Hayder M Al-Kuraishy, Thabat J Al-Maiahy, Ali I Al-Gareeb, Duaa Eliwa, Ahmad Mahmoud Saleh, Hassanat Ramadan Abdel-Aziz, Gaber El-Saber Batiha
Förderung
- Prince Sattam bin Abdulaziz University
Zitieren
APA
Khatap, A. M. F., Al-Kuraishy, H. M., Al-Maiahy, T. J., Al-Gareeb, A. I., Eliwa, D., Saleh, A. M., Abdel-Aziz, H. R., & Batiha, G. E. (2025). Targeting of NF‐κB/NLRP3 Axis in Gestational Diabetes Mellitus. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70188
Vancouver
Khatap AMF, Al-Kuraishy HM, Al-Maiahy TJ, Al-Gareeb AI, Eliwa D, Saleh AM, et al. Targeting of NF‐κB/NLRP3 Axis in Gestational Diabetes Mellitus. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70188
BibTeX
@article{Khatap2025,
author = {Khatap, Asmaa Morgan Farahat and Al-Kuraishy, Hayder M and Al-Maiahy, Thabat J and Al-Gareeb, Ali I and Eliwa, Duaa and Saleh, Ahmad Mahmoud and Abdel-Aziz, Hassanat Ramadan and Batiha, Gaber El-Saber},
title = {Targeting of NF‐κB/NLRP3 Axis in Gestational Diabetes Mellitus},
journal = {American Journal of Reproductive Immunology},
year = {2025},
doi = {10.1111/aji.70188}
}
EUVIMED